TSNDF on OTC
TerrAscend Corp.
The Company is a leading North American cannabis company.4 From its latest annual report
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Village Farms International, Inc., Limoneira CO or iANTHUS CAPITAL HOLDINGS, INC., or pick any stock.
- TickerTSNDF on OTC2
- IndustryAgricultural Production-Crops2
- HeadquartersMississauga, Canada2
- Incorporated inOntario, Canada3
- Business address3610 Mavis Road, Mississauga, A6 L5B 4A73
- Filer category, Emerging growth company3
- Legal formCorporation2
- LEI529900Z66HBZ5381EO492
- StatusActive2
- LEI statusIssued and current2
- Registered address77 City Centre Drive Road, Suite 501, L5B 1M5 Mississauga, Canada2
- Registered withMinistry of Government and Consumer Services, 25650662
See how the biggest companies compare on our leaderboards
The Company is a leading North American cannabis company. The Company has vertically-integrated licensed operations in Pennsylvania, New Jersey, Maryland and California. In addition, the Company has retail operations in Ohio and Ontario, Canada with a majority-owned dispensary in Toronto, Ontario, Canada. Notwithstanding the fact that various states in the United States have implemented medical cannabis laws or have otherwise legalized the use of cannabis, the use of cannabis remains illegal under U.S. federal law for any purpose, by way of the Controlled Substances Act of 1970 (the "Controlled Substances Act").4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue48¢$124.2M
- Other costs30¢$78.0M
- Interest11¢$28.8M
- Income tax11¢$29.5M
Out of $260.6M in revenue.5 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending40¢$8.6M
- Share buybacks2¢$410.0K
- Kept or used elsewhere58¢$12.5M
Out of $21.5M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue, net | $260.6M | $268.1M | $250.5M |
| Cost of sales | $124.2M | $132.2M | $112.5M |
| Gross profit | $136.3M | $135.9M | $138.0M |
| General and administrative | $86.2M | $90.6M | $83.5M |
| Amortization and depreciation | $5.4M | $5.1M | $5.8M |
| Impairment of intangible assets | $2.6M | $0 | $15.5M |
| Impairment of goodwill | $0 | $4.7M | |
| Impairment of property and equipment and right of use assets | $0 | $2.4M | $28.0K |
| Other operating expense (income) | $33.0K | -$1.2M | -$1.3M |
| Total operating expenses | $94.3M | $96.9M | $108.3M |
| Income from operations | $42.0M | $38.9M | $29.7M |
| Finance and other expenses | $35.4M | $33.5M | $32.9M |
| Unrealized and realized loss on investments | $1.4M | $238.0K | $2.6M |
| (Gain) loss from revaluation of contingent consideration | -$1.0M | $2.5M | -$645.0K |
| Loss on extinguishment of debt | $1.4M | $2.1M | $0 |
| Loss (gain) on fair value of derivative liabilities | $535.0K | -$4.5M | -$1.2M |
| Transaction and restructuring costs | $344.0K | ||
| Unrealized and realized foreign exchange (gain) loss | -$687.0K | $940.0K | $2.0K |
| Income (loss) from continuing operations before provision for income taxes | $5.0M | $4.2M | -$4.2M |
| Provision for income taxes | $29.5M | $25.1M | $23.4M |
| Net loss from continuing operations | -$24.5M | -$20.9M | -$27.6M |
| Loss from discontinued operations, net of tax | -$56.8M | -$51.8M | -$59.1M |
| Net loss | -$81.3M | -$72.7M | -$86.7M |
| Foreign currency translation adjustment | $1.0M | -$1.2M | $286.0K |
| Comprehensive loss | -$82.4M | -$71.5M | -$87.0M |
| Common and proportionate Shareholders of the Company | -$29.4M | -$28.5M | -$36.4M |
| Non-controlling interests | $4.9M | $7.6M | $8.8M |
| Common and proportionate Shareholders of the Company | -$87.3M | -$79.0M | -$95.8M |
| Non-controlling interests | $4.9M | $7.6M | $8.8M |
| Continuing operations, basic | -$0 | -$0 | -$0 |
| Continuing operations, diluted | -$0 | -$0 | -$0 |
| Discontinued operations, basic | -$0 | -$0 | -$0 |
| Discontinued operations, diluted | -$0 | -$0 | -$0 |
| Net loss per share - basic | -$0.29 | -$0.28 | -$0.34 |
| Net loss per share - diluted | -$0.29 | -$0.28 | -$0.34 |
| Weighted average number of outstanding common shares, basic | 301.1M shares | 291.5M shares | 279.3M shares |
| Weighted average number of outstanding common shares, diluted | 301.1M shares | 291.5M shares | 279.3M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $37.4M | $26.4M | ||
| Restricted cash | $110.0K | $606.0K | ||
| Accounts receivable, net | $16.9M | $20.2M | ||
| Investments | $362.0K | $1.7M | ||
| Inventory | $34.1M | $39.7M | ||
| Prepaid expenses and other current assets | $8.6M | $5.1M | ||
| Assets from discontinued operations, current | $12.7M | $83.2M | ||
| Total current assets | $110.1M | $176.9M | ||
| Property and equipment, net | $129.9M | $124.2M | ||
| Deposits | $60.0K | $168.0K | ||
| Operating lease right of use assets | $26.7M | $28.8M | ||
| Intangible assets, net | $167.3M | $169.6M | ||
| Goodwill | $109.8M | $106.9M | $106.9M | |
| Other non-current assets | $13.5M | $723.0K | ||
| Total noncurrent assets | $447.3M | $430.3M | ||
| Total assets | $557.4M | $607.2M | ||
| Accounts payable and accrued liabilities | $39.8M | $40.3M | ||
| Deferred revenue | $4.0M | $3.6M | ||
| Convertible debt | $10.4M | |||
| Loans payable | $5.3M | $6.8M | ||
| Contingent consideration payable | $0 | $3.1M | ||
| Operating lease liability | $1.5M | $1.3M | ||
| Derivative liability | $967.0K | $92.0K | ||
| Corporate income tax payable | $5.4M | $11.5M | ||
| Liabilities from discontinued operations | $12.6M | $24.3M | ||
| Total current liabilities | $79.9M | $91.0M | ||
| Loans payable | $203.8M | $183.5M | ||
| Operating lease liability | $28.6M | $30.7M | ||
| Derivative liability | $2.2M | $451.0K | ||
| Convertible debt | $6.9M | $9.1M | ||
| Deferred income tax liability | $8.0M | $8.4M | ||
| Contingent consideration payable | $0 | $172.0K | ||
| Liability on uncertain tax position | $128.8M | $107.0M | $79.6M | |
| Other long term liabilities | $86.0K | $85.0K | ||
| Total non-current liabilities | $378.4M | $339.4M | ||
| Total liabilities | $458.4M | $430.4M | ||
| Common shares, no par value, unlimited shares authorized; 308,532,518 and 293,232,131 shares outstanding as of December 31, 2025 and December 31, 2024 respectively | $0 | $0 | ||
| Treasury stock, no par value; nil and 129,500 shares outstanding as of December 31, 2025 and December 31, 2024, respectively | $0 | $0 | ||
| Additional paid in capital | $960.2M | $952.5M | ||
| Accumulated other comprehensive income | $2.0M | $3.0M | ||
| Accumulated deficit | -$864.7M | -$778.5M | ||
| Non-controlling interest | $1.5M | -$144.0K | -$1.8M | |
| Total shareholders' equity | $99.0M | $176.8M | $240.7M | $321.2M |
| Total liabilities and shareholders' equity | $557.4M | $607.2M | ||
| Common stock, shares, outstanding | 308.5M shares | 293.2M shares | ||
| Treasury stock, shares outstanding | 0 shares | 129.5K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $37.4M | $26.4M | ||
| Restricted cash | $110.0K | $606.0K | ||
| Accounts receivable, net | $16.9M | $20.2M | ||
| Investments | $362.0K | $1.7M | ||
| Inventory | $34.1M | $39.7M | ||
| Prepaid expenses and other current assets | $8.6M | $5.1M | ||
| Assets from discontinued operations, current | $12.7M | $83.2M | ||
| Total current assets | $110.1M | $176.9M | ||
| Property and equipment, net | $129.9M | $124.2M | ||
| Deposits | $60.0K | $168.0K | ||
| Operating lease right of use assets | $26.7M | $28.8M | ||
| Intangible assets, net | $167.3M | $169.6M | ||
| Goodwill | $109.8M | $106.9M | $106.9M | |
| Other non-current assets | $13.5M | $723.0K | ||
| Total noncurrent assets | $447.3M | $430.3M | ||
| Total assets | $557.4M | $607.2M | ||
| Accounts payable and accrued liabilities | $39.8M | $40.3M | ||
| Deferred revenue | $4.0M | $3.6M | ||
| Convertible debt | $10.4M | |||
| Loans payable | $5.3M | $6.8M | ||
| Contingent consideration payable | $0 | $3.1M | ||
| Operating lease liability | $1.5M | $1.3M | ||
| Derivative liability | $967.0K | $92.0K | ||
| Corporate income tax payable | $5.4M | $11.5M | ||
| Liabilities from discontinued operations | $12.6M | $24.3M | ||
| Total current liabilities | $79.9M | $91.0M | ||
| Loans payable | $203.8M | $183.5M | ||
| Operating lease liability | $28.6M | $30.7M | ||
| Derivative liability | $2.2M | $451.0K | ||
| Convertible debt | $6.9M | $9.1M | ||
| Deferred income tax liability | $8.0M | $8.4M | ||
| Contingent consideration payable | $0 | $172.0K | ||
| Liability on uncertain tax position | $128.8M | $107.0M | $79.6M | |
| Other long term liabilities | $86.0K | $85.0K | ||
| Total non-current liabilities | $378.4M | $339.4M | ||
| Total liabilities | $458.4M | $430.4M | ||
| Common shares, no par value, unlimited shares authorized; 308,532,518 and 293,232,131 shares outstanding as of December 31, 2025 and December 31, 2024 respectively | $0 | $0 | ||
| Treasury stock, no par value; nil and 129,500 shares outstanding as of December 31, 2025 and December 31, 2024, respectively | $0 | $0 | ||
| Additional paid in capital | $960.2M | $952.5M | ||
| Accumulated other comprehensive income | $2.0M | $3.0M | ||
| Accumulated deficit | -$864.7M | -$778.5M | ||
| Non-controlling interest | $1.5M | -$144.0K | -$1.8M | |
| Total shareholders' equity | $99.0M | $176.8M | $240.7M | $321.2M |
| Total liabilities and shareholders' equity | $557.4M | $607.2M | ||
| Common stock, shares, outstanding | 308.5M shares | 293.2M shares | ||
| Treasury stock, shares outstanding | 0 shares | 129.5K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss from continuing operations | -$24.5M | -$20.9M | -$27.6M |
| Accretion and accrued interest | $7.9M | $10.9M | $9.0M |
| Depreciation of property and equipment and amortization of intangible assets | $15.6M | $14.6M | $14.8M |
| Amortization of operating right-of-use assets | $1.6M | $1.6M | $1.3M |
| Share-based compensation | $5.0M | $9.7M | $7.7M |
| Deferred income tax expense recovery | -$532.0K | $1.4M | -$10.3M |
| Loss (gain) on fair value of derivative liabilities | $535.0K | -$4.5M | -$181.0K |
| Unrealized and realized loss on investments | $1.4M | $238.0K | $2.6M |
| (Gain) loss from revaluation of contingent consideration | -$1.0M | $2.5M | -$645.0K |
| Provision for expected credit loss (recovery) | $1.7M | $3.1M | $0 |
| Loss on extinguishment of debt | $1.4M | $2.1M | $0 |
| Unrealized and realized foreign exchange (gain) loss | -$687.0K | $940.0K | $2.0K |
| Impairment and other | $2.6M | $1.2M | $19.5M |
| Receivables | $1.6M | -$5.3M | -$8.7M |
| Inventory | $5.9M | $1.2M | -$4.2M |
| Accounts payable and accrued liabilities | -$4.5M | -$316.0K | $9.1M |
| Income taxes paid and tax related liabilities | $20.5M | $28.7M | $39.0M |
| Prepaid expense and other current assets | -$144.0K | $52.0K | $1.1M |
| Other assets and liabilities | -$592.0K | -$801.0K | -$694.0K |
| Net cash provided by operating activities - continuing operations | $33.9M | $46.2M | $51.9M |
| Net cash used in operating activities - discontinued operations | -$12.4M | -$8.3M | -$24.4M |
| Net cash provided by operating activities | $21.5M | $38.0M | $27.5M |
| Investment in property and equipment | -$8.6M | -$6.9M | -$4.9M |
| Investment in note receivable, net of interest received | $165.0K | -$1.5M | |
| Investment in intangible assets | -$738.0K | -$1.2M | -$1.7M |
| Cash portion of consideration paid in acquisition | -$5.1M | -$250.0K | -$16.8M |
| Deposits for business acquisition | -$3.4M | ||
| Success fees related to Alternative Treatment Center license | -$3.0M | ||
| Net cash used in investing activities- continuing operations | -$17.7M | -$9.8M | -$26.3M |
| Net cash provided by (used in) investing activities - discontinued operations | $3.1M | -$2.5M | $10.1M |
| Net cash used in investing activities | -$14.6M | -$12.2M | -$16.2M |
| Proceeds from loans payable, net of transaction costs | $78.9M | $129.4M | $23.9M |
| Loan principal paid | -$70.5M | -$137.0M | -$42.8M |
| Loan exit fee paid | -$233.0K | -$500.0K | -$1.2M |
| Capital distributions paid to non-controlling interests | -$3.2M | -$7.3M | -$11.6M |
| Payments of contingent consideration | -$386.0K | ||
| Payments made for financing obligations and finance lease | -$276.0K | -$55.0K | |
| Repurchases of common shares | -$410.0K | -$215.0K | |
| Proceeds from private placement, net of share issuance costs | $20.8M | ||
| Proceeds from options exercised | $98.0K | ||
| Employee retention credit | $7.2M | ||
| Net cash provided by (used in) financing activities- continuing operations | $4.2M | -$15.9M | -$3.6M |
| Net cash used in financing activities- discontinued operations | -$8.8M | -$8.9M | |
| Net cash (used in) provided by financing activities | $4.2M | -$24.7M | -$12.5M |
| Net increase (decrease) in cash and cash equivalents and restricted cash during the year | $11.1M | $987.0K | -$1.2M |
| Net effects of foreign exchange | -$572.0K | $653.0K | -$168.0K |
| Cash paid (received) for income tax, net | $9.4M | -$5.0M | -$3.3M |
| Interest paid | $27.9M | $23.8M | $23.0M |
| Lease termination fee paid | $2.0M | $271.0K | $379.0K |
| Equity and warrant liability issued for acquisitions and non-controlling interest | $1.3M | $4.7M | $8.6M |
| Change in accured capital expenditures | -$144.0K | -$1.1M | $1.5M |
| Equity issued for price protection on contingent consideration | $1.9M | $693.0K | |
| Warrant issued as consideration for services | $1.0M | ||
| Debt instrument issued as consideration for acquisitions | $13.0M | $11.7M | |
| Shares issued for legal and liability settlement | $794.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led TerrAscend Corp., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerZiad Ghanem May 9, 2023 to now11
- PresidentZiad Ghanem Jan 11, 2022 to now12
- Chief financial officerKeith Stauffer Jan 3, 2022 to now13
- Chief operating officerZiad Ghanem Jan 11, 2022 to Mar 31, 202312
Board members and other officers (9)
- CHIEF PEOPLE AND LEGAL OFFICERLynn K. Gefen Nov 22, 2024 to now14
- Board memberZiad Ghanem Aug 12, 2026 to now15
- Board memberEdward J. Schutter Jan 3, 2022 to now16
- Board memberRichard Mavrinac Jan 3, 2022 to Feb 15, 202317
- Board memberCraig A. Collard Jan 10, 2022 to now18
- Board memberKara Dioguardi Mar 8, 2022 to now19
- Board memberLisa Swartzman Apr 1, 2022 to Jun 26, 202320
- Board memberIra Duarte Dec 9, 2022 to now21
- General counselLynn K. Gefen Jun 2, 2022 to Apr 10, 202422
Named in SEC Form D filings
People the company listed in its private-offering notices.
Timeline
Filings
271 filings to the SEC since October 2021: 7 annual reports, 14 quarterly reports, 54 major events, 146 insider forms, 11 large holders, 1 private raises, 38 other. The latest 20:
- Aug 25, 20268-K EDGAR
- Aug 12, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Aug 6, 20268-K EDGAR
- Aug 6, 202610-Q EDGAR
- Jul 8, 2026D EDGAR
- Jul 6, 2026DEFA14A EDGAR
- Jul 6, 2026DEF 14A EDGAR
- Jun 29, 20268-K EDGAR
- Jun 25, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Jun 25, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Jun 25, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Jun 25, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Jun 25, 2026PRE 14A EDGAR
- Jun 25, 20268-K EDGAR
- Jun 25, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 15, 20268-K EDGAR
- May 7, 20268-K EDGAR
- May 7, 202610-Q EDGAR
- Apr 28, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Apr 28, 20263 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
The 271 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
60 open-market trades by officers, directors and large owners since October 2021: 52 buys and 8 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 24, 2025 | SCHUTTER EDWARD JDirector | Sale | 296,174 | $0.44 | $130.3K | Form 4 |
| Nov 21, 2025 | SCHUTTER EDWARD JDirector | Sale | 250,000 | $0.41 | $102.5K | Form 4 |
| Aug 27, 2025 | Wild Jason G.10% owner | Sale | 8,415,414 | Form 4 | ||
| Jul 18, 2025 | Stauffer KeithCFO | Sale | 52,500 | $0.39 | $20.5K | Form 4 |
| May 12, 2025 | SCHUTTER EDWARD JDirector | Buy | 1,041,021 | $0.39 | $406.0K | Form 4 |
| Dec 22, 2023 | JW Asset Management, LLCExecutive Chairman | Buy | 12,000 | $1.46 | $17.5K | Form 4 |
| Dec 18, 2023 | Wild Jason G.10% owner | Buy | 15,000 | $1.39 | $20.9K | Form 4 |
| Dec 11, 2023 | JW Asset Management, LLCExecutive Chairman | Buy | 10,000 | $1.53 | $15.3K | Form 4 |
| Dec 6, 2023 | JW Asset Management, LLCExecutive Chairman | Buy | 10,000 | $1.59 | $15.9K | Form 4 |
| Dec 4, 2023 | Wild Jason G.10% owner | Buy | 15,000 | $1.58 | $23.7K | Form 4 |
| Nov 20, 2023 | JW GP, LLC10% owner | Buy | 12,000 | $1.49 | $17.9K | Form 4 |
| Nov 17, 2023 | JW Partners, LP10% owner | Buy | 18,200 | $1.51 | $27.5K | Form 4 |
| Nov 15, 2023 | JW GP, LLC10% owner | Buy | 15,000 | $1.56 | $23.4K | Form 4 |
| Sep 28, 2023 | JW GP, LLC10% owner | Buy | 75,000 | $2.04 | $153.0K | Form 4 |
| Sep 25, 2023 | JW Partners, LP10% owner | Buy | 30,000 | $2.08 | $62.4K | Form 4 |
| Sep 22, 2023 | JW GP, LLC10% owner | Buy | 10,000 | $2.10 | $21.0K | Form 4 |
| Sep 21, 2023 | JW Partners, LP10% owner | Buy | 5,000 | $2.01 | $10.1K | Form 4 |
| Sep 20, 2023 | JW Partners, LP10% owner | Buy | 27,450 | $2.01 | $55.2K | Form 4 |
| Sep 19, 2023 | Wild Jason G.10% owner | Buy | 15,000 | $2.02 | $30.3K | Form 4 |
| Sep 18, 2023 | JW Asset Management, LLCExecutive Chairman | Buy | 25,000 | $2.06 | $51.5K | Form 4 |
All 60 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- JW Asset Management, LLCSCHEDULE 13D/A, 7 filings Feb 14, 2022 to Aug 27, 202524
- Michael HermizSC 13G, 1 filing Mar 9, 202325
- Cowen Financial Products LLCSC 13G/A, 3 filings Jan 19, 2022 to Jan 25, 202326
Money raised
Private offerings the company reported to the SEC on Form D.
- Jun 23, 2026Raised $21.8 million in a private offering of debt Form D: $25 million offered in all Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Sterling Capital Management LLC | 80 | $54 | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARZiad Ghanem, Chief executive officer
- 12SEC EDGARZiad Ghanem, President
- 13
- 14
- 15SEC EDGARZiad Ghanem, Board member
- 16SEC EDGAREdward J. Schutter, Board member
- 17SEC EDGARRichard Mavrinac, Board member
- 18SEC EDGARCraig A. Collard, Board member
- 19SEC EDGARKara Dioguardi, Board member
- 20SEC EDGARLisa Swartzman, Board member
- 21SEC EDGARIra Duarte, Board member
- 22SEC EDGARLynn K. Gefen, General counsel
- 23
- 24
- 25
- 26